UPDATE 1-Foxconn CEO says investment for display plant in U.S. would exceed $7 bln
* Has considered plan for years; leaked by Softbank in December (Adds further comment from Foxconn CEO)
Jan 5 Juniper Pharmaceuticals Inc :
* Prototype formulation development for jnp-0301 is underway, with ind-enabling studies planned for 2017
* Company expects to initiate definitive sheep studies by year-end 2017 for jnp-0301
* Juniper pharmaceuticals inc- sheep studies could potentially enable an ind submission in first half of 2018 for jnp-0301 Source text for Eikon: Further company coverage:
KINSHASA, Jan 22 China Molybdenum Co Ltd (CMOC) said on Sunday that it has signed an agreement with Chinese private equity firm BHR to support BHR's acquisition of a 24 percent stake in Democratic Republic of Congo's giant Tenke copper mine.
WASHINGTON, Jan 21 President Donald Trump is ordering federal agencies to undermine Obamacare through regulatory action, a move that could weaken enforcement of the requirement for Americans to buy health coverage and give insurers leeway to drop some benefits.